FORM SC 13G

Company

Aspire Biopharma Holdings, Inc.

Filed

February 28, 2022

Accession Number

0001062993-22-005867

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →